A study affirms that gender-affirming care significantly reduces suicidality and depression in transgender individuals.
This study is the first of its kind. Conducting randomized controlled trials for gender-affirming care, similar to many conventional medical treatments, is unethical — a fact that the researchers in this study acknowledge. Withholding medication that has years of clinical backing and a plethora of studies would likely face rejection from most institutional review boards. The challenge isn’t unique to gender-affirming care.
In order to get around the ethical problems of withholding care, the researchers studied only adults, and opted for a shorter follow-up period. The researchers point out that by doing this, the control group would not be disadvantaged for very long, and that such a wait period would be deemed acceptable for transgender people who want to contribute to such important research. This means that such a trial could be conducted ethically.
The improvement in depression and suicidality underscores the substantial benefits of gender-affirming care. The reduction scores align with the much longer observational studies, which typically report a 40-73% decrease in suicidality. While this study alone doesn’t confirm long-term advantages, when viewed alongside the extensive clinical experiences of physicians and numerous other studies indicating long-term benefits of such care, it establishes the importance of this care.
Recently, anti-trans activists have pointed to the absence of RCTs as grounds to prohibit the care, neglecting to mention that the evidence for gender-affirming care aligns with that of most other medical treatments with similar absences. With the release of this study, this argument is no longer tenable.
So are we! That’s why we’re on a mission to shake things up and bring you the stories and perspectives that often go untold in mainstream media. But being a radically, unapologetically independent news site isn’t easy , and we rely on reader support to keep the lights on.We’re not asking for a handout, we’re asking for an investment: Invest in a nonprofit news site that’s not afraid to ruffle a few feathers, not afraid to stand up for what’s right, and not afraid to tell it like it is.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Johnny Depp Stars in First Dior Sauvage Commercial Since Amber Heard Trial: WatchJohnny Depp stars in a new commercial for Dior's Sauvage fragrance, which marks his first advertisement promoting the fragrance following his trial against ex-wife Amber Heard in 2022
続きを読む »
First week of Attorney General Ken Paxton's impeachment trial concludes: 2 distinct narratA fourth day of witness testimony put a wrap on the first week of Attorney General Ken Paxton's impeachment trial Friday.
続きを読む »
First week of Attorney General Ken Paxton's impeachment trial concludes: Two distinct narratives emergeA fourth day of witness testimony put a wrap on the first week of Attorney General Ken Paxton's impeachment trial Friday.
続きを読む »
In first tech antitrust trial in decades, DOJ takes on GoogleProsecutors allege Google used its search engine’s monolithic popularity to illegally throttle competition. But the DOJ case has implications on the company’s broader ambitions.
続きを読む »
California Opens Digital ID Pilot Program To 1.5 Million ResidentsThe program is free, and it's first come, first served.
続きを読む »
Rep. Nancy Pelosi to run for re-election to House seatPelosi, the first woman to serve as speaker, was first elected to office in 1987.
続きを読む »